Laboratory Corporation of America Holdings's (LCA) proposed purchase of Dianon Systems Inc. [See Deal], followed by the announcement of Welsh, Carson, Anderson & Stowe's bid for AmeriPath Inc. , reflect different paths taken by two fierce competitors. They are also the inevitable consequence of consolidation in laboratory testing at the national level.
Dianon and AmeriPath have both spent the better part of a decade striving to become national providers of anatomic pathology...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?